You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-small cell lung cancer (stage III or IV)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer, Nonsmall Cell, Stage IIIA, Lung Cancer Non-Small Cell Stage IIIB, Lung Cancer Non-Small Cell Stage III Trial in

Not yet recruiting
  • Lung Cancer, Nonsmall Cell, Stage IIIA
  • +4 more
  • E-health ecosystem of stepped psychosocial care
  • Usual psychosocial care
  • L'Hospitalet De Llobregat, Catalunya, Spain
    Institut Català d'Oncologia
Aug 9, 2022

Metastatic Lung Non-Small Cell Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Orange,

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +8 more
  • Orange, California
  • +2 more
Aug 10, 2022

Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Rochester

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +7 more
  • Exercise Counseling
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Oct 7, 2022

Oncology, NSCLC Stage IV, NSCLC, Stage III Trial in Drammen (UV1, Sagramostim, Anti-PD-1/PD-L1 treatment)

Recruiting
  • Oncology
  • +2 more
  • UV1
  • +2 more
  • Drammen, Viken, Norway
    Vestre Viken Health Trust
Aug 15, 2022

Lung Adenocarcinoma, Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United States (biological, procedure,

Recruiting
  • Lung Adenocarcinoma
  • +2 more
  • Ipilimumab
  • +5 more
  • Conroe, Texas
  • +4 more
May 25, 2022

Lung Non-Small Cell Carcinoma, Positive Surgical Margin, Resected Mass Trial in Buffalo (Quality-of-Life Assessment,

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +9 more
  • Quality-of-Life Assessment
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 2, 2022

Stage II-III NSCLC Trial in Shanghai (4cycles(Toripalimab IV 240mg + platinum-based doublet chemo)+13 cycles(Toripalimab IV

Recruiting
  • Stage II-III Non-small Cell Lung Cancer
  • 4cycles(Toripalimab IV 240mg + platinum-based doublet chemotherapy)+13 cycles(Toripalimab IV 240mg); Biological: Toripalimab
  • 4cycles(Placebo + platinum-based doublet chemotherapy)+13 cycles(Placebo )
  • Shanghai, China
    Shanghai Chest Hospital
Apr 12, 2022

Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma Trial

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +10 more
  • Antineoplastic Immune Cell
  • +4 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Aug 12, 2022

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

NSCLC Trial in China (Atezolizumab, Placebo, Bevacizumab)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Beijing City, China
  • +22 more
Dec 7, 2022

Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Portland (Best Practice,

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +15 more
  • Best Practice
  • +2 more
  • Portland, Oregon
  • +1 more
Jun 8, 2022

Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell

Recruiting
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • +9 more
  • Duarte, California
  • +4 more
Aug 17, 2022

Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,

Recruiting
  • Advanced Bile Duct Carcinoma
  • +33 more
  • Sacramento, California
  • +6 more
Aug 11, 2022

Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Stage I Cutaneous Squamous Cell Carcinoma of the Head and

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +17 more
  • Best Practice
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 19, 2022

Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial (Fluorine

Withdrawn
  • Advanced Lung Non-Small Cell Carcinoma
  • +8 more
  • Fluorine F 18 Ara-G
  • (no location specified)
Jan 24, 2022

Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung

Active, not recruiting
  • Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +5 more
  • Sacramento, California
  • +17 more
Aug 2, 2022

Appropriate Dosing to Optimise Personalised Cancer Treatments

Completed
  • Melanoma Stage III
  • +5 more
  • Dried blood Spot (DBS)
  • Venous blood sampling
  • Dundee, Scotland, United Kingdom
    NHS Tayside and University of Dundee
Feb 25, 2022

Solid Tumor, Stage III Pancreatic Cancer, Stage IIIA Breast Cancer Trial in Atlanta (Carboplatin, Cisplatin, Palbociclib)

Active, not recruiting
  • Solid Neoplasm
  • +16 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Feb 28, 2022

NSCLC Trial in China (Atezolizumab, Pemetrexed, Carboplatin)

Recruiting
  • Non-Small Cell Lung Cancer
  • Beijing City, China
  • +20 more
Aug 5, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,

Recruiting
  • Advanced Bladder Carcinoma
  • +34 more
  • Atezolizumab
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +15 more
  • Los Angeles, California
  • +1 more
Aug 5, 2022

Advanced Pleural Malignant Mesothelioma, HLA-A*0201 Positive Cells Present, Recurrent Non-Small Cell Lung Carcinoma Trial in

Terminated
Has Results
  • Advanced Pleural Malignant Mesothelioma
  • +10 more
  • Aldesleukin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2021

Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Conroe, Texas
  • +4 more
Dec 5, 2022

AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United

Recruiting
  • AIDS-Related Non-Hodgkin Lymphoma
  • +29 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Birmingham, Alabama
  • +12 more
Aug 4, 2022